Sidney Kimmel Cancer Center at Jefferson | Strategic Alliance Partners

Latest from Sidney Kimmel Cancer Center at Jefferson

Dr. Gomella on the Role of Genetic Testing in Prostate Cancer

January 11, 2021

Video

Leonard G. Gomella, MD, discusses the role of genetic testing in prostate cancer.

Role for Somatic, Inherited Genetic Testing in Prostate Cancer Continues to Grow

January 03, 2021

Article

Leonard G. Gomella, MD, discusses the growing importance of genetic testing in prostate cancer.

Dr. Edith Mitchell Elected to Fellowship in the Royal College of Physicians of London

December 07, 2020

Article

Edith P. Mitchell, MD, FACP, FCPP, FRCP, Associate Director for Diversity Affairs at the Sidney Kimmel Cancer Center – Jefferson Health, has been recognized as a fellow of the Royal College of Physicians of London.

Giri and Gomella on Fostering a New Framework for Genetic Testing Guidelines in Prostate Cancer

September 14, 2020

Podcast

In our exclusive interview, Dr. Giri and Dr. Gomella discuss the rationale to create the first multidisciplinary, consensus-driven framework for prostate cancer genetic testing, the importance of having a multidisciplinary team weigh in on the recommendations, and key aspects of the guidelines that could have clinical implications for men in this space.

NCI Awards Funding to Sidney Kimmel Cancer Center - Jefferson Health to Assess Impact of Telehealth During COVID-19 Pandemic

July 20, 2020

Article

The National Cancer Institute has awarded the Sidney Kimmel Cancer Center – Jefferson Health a supplemental grant to study the role of telehealth in delivering cancer care during the COVID-19 pandemic.

Dr. Kelly on Efficacy of Radium-223 Dichloride and Niraparib in Patients With mCRPC

June 10, 2020

Video

William K. Kelly, DO, discusses results from a phase 1b dose-finding study evaluating the combination of radium-223 dichloride (Xofigo) plus niraparib (Zejula) in patients with metastatic castration-resistant prostate cancer.